SGCB and cancer: Although current clinical uses of sGC activators are limited to pulmonary hypertension and heart failure, other promising results exist for a host of other diseases including chronic kidney disease, systemic sclerosis, COPD, and even cancer [298,299,300,301,302,303,304,305].